Evidence map›Paper›PMID 40281205›Full record

ArticleNature medicine2025

Author Correction: T cell malignancies after CAR T cell therapy in the DESCAR-T registry.

Remy Dulery, Vincent Guiraud, Sylvain Choquet, Catherine Thieblemont, Emmanuel Bachy, Stéphane Barete, Ève Todesco, Bertrand Arnulf, Nicolas Boissel, André Baruchel and 3 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Remy Dulery *Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, INSERM, UMRs 938, Centre de recherche Saint-Antoine (CRSA), Paris, France. remy.dulery@aphp.fr.ORCID http://orcid.org/0000-0002-5024-1713
Vincent Guiraud *Department of Virology, Sorbonne University, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.ORCID http://orcid.org/0000-0002-4301-3771
Sylvain Choquet *Department of Clinical Hematology, Sorbonne University, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID http://orcid.org/0000-0002-7791-0470
Catherine ThieblemontHemato-oncology, Paris Cité University, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, France.ORCID http://orcid.org/0000-0002-9941-2448
Emmanuel BachyHematology Department, Hospices Civils de Lyon, Pierre-Bénite, France.ORCID http://orcid.org/0000-0003-2694-7510
Stéphane BareteUnit of Dermatology, Sorbonne University, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID http://orcid.org/0000-0003-1593-9750
Ève TodescoDepartment of Virology, Sorbonne University, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.ORCID http://orcid.org/0000-0002-9260-8616
Bertrand ArnulfDepartment of Immuno-Hematology, Paris Cité University, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
Nicolas BoisselHematology Adolescents and Young Adult Unit, Paris Cité University, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, URP-3518, Institut de Recherche Saint-Louis, Paris, France.ORCID http://orcid.org/0000-0003-2091-7927
André BaruchelDepartment of Pediatric Hematology and Immunology, Paris Cité University, Hôpital Universitaire Robert Debré, Assistance Publique-Hôpitaux de Paris, EA3518, Institut de Recherche Saint-Louis, Paris, France.
Jacques-Olivier BayDepartment of Adult Clinical Hematology and Cellular Therapy, CHU Clermont-Ferrand, Clermont-Ferrand, France.ORCID http://orcid.org/0000-0002-7032-5180
Steven Le GouillDepartment of Hematology, Versailles Saint-Quentin University, Institut Curie, Laboratoire d'Imagerie Translationnelle en Oncologie (LITO), U1288 Inserm/Institut Curie Centre de recherche, Saint-Cloud, France.
Roch HouotDepartment of Hematology, University Hospital of Rennes, UMR U1236, INSERM, University of Rennes, French Blood Establishment, Rennes, France.ORCID http://orcid.org/0000-0003-1729-8213

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40281205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.